Simultaneously targeting Bcl-2 and Akt pathways sensitizes nasopharyngeal carcinoma to tumor necrosis factor-related apoptosis-inducing ligand

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 1, 2012, Pages 88-95

  Li, Shi Sheng ^a   Tang, Qing Lai ^a   Wang, Shu Hui ^a   Wang, Shuang ^a   Yang, Xin Ming ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Akt; Bcl 2; nasopharyngeal carcinoma; resistance; TRAIL

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA ACTIN; CASPASE 3; CASPASE 8; CASPASE 9; DEATH RECEPTOR 4; DEATH RECEPTOR 5; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; WORTMANNIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; FIBROBLAST CULTURE; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84863178344     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1031     Document Type: Article

References (30)

1. Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 2000;256:58.
2. Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815.
3. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1:19.
4. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481.
5. Siddiqui IA, Malik A, Adhami VM, et al. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 2008;27:2055.
6. Szliszka E, Zydowicz G, Janoszka B, et al. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol 2011;38:4941.
7. Li G, Xie L, Zhou G, et al. Active immunotherapy with antiidiotypic antibody for patients with nasopharyngeal carcinoma (NPC). Cancer Biother Radiopharm 2002;17:673.
8. Isobe K, Ito H, Shigematsu N, et al. Advanced nasopharyngeal carcinoma treated with chemotherapy and radiotherapy: Distant metastasis and local recurrence. Int J Oncol 1998;12:1183.
9. Ren SP, Wang L, Wang H, et al. Gene therapy for human nasopharyngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model. Cancer Biother Radiopharm 2008;23:591.
10. Teng MS, Brandwein Gensler MS, Teixeira MS, et al. A study of TRAIL receptors in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2005;131:407.
11. Chen LC, Chung IC, Hsueh C, et al. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ 2010;17:1463.
12. Ozoren N, Fisher MJ, Kim K. Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 2000;16:917.
13. Yin ZH, Ren CP, Li F, et al. Suppression of bcl-2 gene by RNA interference increases chemosensitivity to cisplatin in nasopharyngeal carcinoma cell line CNE1. Acta Biochim Biophys Sin 2004;36:749.
14. Zhang XM, Wang Q, Ling MT, et al. Anti-apoptotic role of TWIST and its association with Akt pathway in mediating taxol resistance in nasopharyngeal carcinoma cells. Int J Cancer 2007;120:1891.
15. Fulda S, Meyer E, Debatin KM. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 2002;21:2283.
16. Sun SY, Yue P, Zhou JY, et al. Overexpression of Bcl-2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun 2001;280:788.
17. Oka N, Tanimoto S, Taue R, et al. Role of phosphatidylinositol- 3 kinase/Akt pathway in bladder cancer cell apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Sci 2006;97:1093.
18. Medema JP, Scaffidi C, Kischkel FC, et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997;16:2794.
19. Tschopp J, Irmler M, Thome M. Inhibition of fas death signals by FLIPs. Curr Opin Immunol 1998;10:552.
20. Zou H, Li Y, Liu X, et al. An APAF-1:cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549.
21. Salvesen GS, Duckett CS. Apoptosis: IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol 2002;3:401.
22. Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000;256:42.
23. Chen MK, Lai JC, Chang CC, et al. Prognostic impact of Bcl-2 expression on advanced nasopharyngeal carcinoma. Head Neck 2008;10:1052.
24. Hu ZY, Zhu XF, Zhong ZD, et al. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosisn and suppresses tumor growth in nasopharyngeal carcinoma xenografts. Int J Cancer 2008;123:2418.
25. Cory S, Adams JM. Killing cancer cells by flipping the Bcl-2/ Bax switch. Cancer Cell 2005;8:5.
26. Brognard J, Clark AS, Ni Y, et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res 2001;61:3986.
27. Xia S, Zhao Y, Yu S, et al. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. Cancer Biother Radiopharm 2010;25:317.
28. Datta SR, Brunet A, Greenberg ME. Cellular survival: A play in three Akts. Genes Dev 1999;13:2905.
29. Goncharenko-Khaider N, Lane D, Matte I, et al. The inhibition of Bid expression by Akt leads to resistance to TRAILinduced apoptosis in ovarian cancer cells. Oncogene 2010;29:5523.
30. Wang J, Lobito AA, Shen F, et al. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP. Eur J Immunol 2000;30:155.